Behavioral changes induced by cocaine in mice are modified by a hyperlipidic diet or recombinant leptin

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 12, 2006, Pages 1625-1635

  Erhardt, E ^a   Zibetti, L C E ^a   Godinho, J M ^a   Bacchieri, B ^a   Barros, H M T ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Cocaine; Hyperlipidic diet; Interaction; Leptin; Mice

Indexed keywords

COCAINE; LEPTIN; RECOMBINANT LEPTIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; ETHOLOGY; EXPLORATORY BEHAVIOR; FOOD COMPOSITION; FOOD INTAKE; GROOMING; IMMOBILIZATION; LIPID DIET; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PHYSICAL ACTIVITY; PROTEIN SYNTHESIS; REARING; SWIMMING; TRANQUILIZING ACTIVITY;

MUS; RODENTIA;

EID: 33847655211     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006001200014     Document Type: Article

References (40)

1. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999; 20: 68-100.
2. Harris RB, Zhou J, Redmann SM Jr, Smagin GN, Smith SR, Rodgers E, et al. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 1998; 139: 8-19.
3. Inui A. Feeding and body-weight regulation by hypothalamic neuropeptides - mediation of the actions of leptin. Trends Neurosci 1999; 22: 62-67.
4. Prolo P, Wong ML, Licinio J. Leptin. Int J Biochem Cell Biol 1998; 30: 1285-1290.
5. Buchanan C, Mahesh V, Zamorano P, Brann D. Central nervous system effects of leptin. Trends Endocrinol Metab 1998; 9 (Suppl IV): 146-150.
6. Rodrigues AM, Boguszewski CL. Hormônios e neurotransmissores na regulação da ingestão alimentar. Arq Bras Endocrinol Metabol 1999; 43 (Suppl II): S41B-S47B.
7. Marti A, Berraondo B, Martinez JA. Leptin: physiological actions. J Physiol Biochem 1999; 55: 43-49.
8. O'Neill L. A role for leptin in autoimmunity? Trends Pharmacol Sci 2001; 22: 341.
9. Caprio M, Fabbrini E, Isidori AM, Aversa A, Fabbri A. Leptin in reproduction. Trends Endocrinol Metab 2001; 12: 65-72.
10. Antonijevic IA, Murck H, Frieboes RM, Horn R, Brabant G, Steiger A. Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiatr Res 1998; 32: 403-410.
11. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuijper JL. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 1997; 82: 561-565.
12. Auwerx J, Staels B. Leptin. Lancet 1998; 351: 737-742.
13. Lagiou P, Signorello LB, Mantzoros CS, Trichopoulos D, Hsieh CC, Trichopoulou A. Hormonal, lifestyle, and dietary factors in relation to leptin among elderly men. Ann Nutr Metab 1999; 43: 23-29.
14. Hohmann JG, Teklemichael DN, Weinshenker D, Wynick D, Clifton DK, Steiner RA. Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin. Mol Cell Biol 2004; 24: 2978-2985.
15. Clapham JC, Arch JR, Tadayyon M. Anti-obesity drugs: a critical review of current therapies and future opportunities. Pharmacol Ther 2001; 89: 81-121.
16. Leibowitz SF, Alexander JT. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 1998; 44: 851-864.
17. Korner J, Chua SC Jr, Williams JA, Leibel RL, Wardlaw SL. Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats. Neuroendocrinology 1999; 70: 377-383.
18. Suomalainen M, Mannisto PT. Lack of effect of leptin on the behaviour of mice predicting the level of anxiety and depression. Pharmacol Toxicol 1998; 83: 139-142.
19. Asakawa A, Inui A, Inui T, Katsuura G, Fujino MA, Kasuga M. Leptin treatment ameliorates anxiety in ob/ob obese mice. J Diabetes Complications 2003; 17: 105-107.
20. Galduroz JC, Noto AR, Nappo SA, Carlini EA. Trends in drug use among students in Brazil: analysis of four surveys in 1987, 1989, 1993 and 1997. Braz J Med Biol Res 2004; 37: 523-531.
21. Blednov YA, Walker D, Harris RA. Blockade of the leptin-sensitive pathway markedly reduces alcohol consumption in mice. Alcohol Clin Exp Res 2004; 28: 1683-1692.
22. Ministério da Saúde (Brazil). Coordenação-Geral da Político de Alimentação e Nutrição. http://dtr2004.saude.gov.br/nutricao/sobrepeso.php. Accessed October 12, 2005.
23. Considine RV, Caro JF. Leptin: genes, concepts and clinical perspective. Horm Res 1996; 46: 249-256.
24. Miller NS, Gold MS, Smith DE. Manual of therapeutics for addictions. 1st edn. New York: Johns Wiley & Sons Inc.; 1997.
25. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57BI/6J mice. Int J Obes Relat Metab Disord 2000; 24: 639-646.
26. Ahren B, Baldwin RM, Havel PJ. Pharmacokinetics of human leptin in mice and rhesus monkeys. Int J Obes Relat Metab Disord 2000; 24: 1579-1585.
27. Harro J. Measurement of exploratory behavior in rodents. J Neurosci Methods 1993; 14: 359-377.
28. Andreatini R, Bacellar LF. The relationship between anxiety and depression in animal models: a study using the forced swimming test and elevated plus-maze. Braz J Med Biol Res 1999; 32: 1121-1126.
29. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
30. Stout JC, Weiss JM. An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulations. Pharmacol Biochem Behav 1994; 47: 459-465.
31. Rodgers RJ, Cao BJ, Dalvi A, Holmes A. Animai models of anxiety: an ethological perspective. Braz J Med Biol Res 1997; 30: 289-304.
32. Buyse M, Bado A, Dauge V. Leptin decreases feeding and exploratory behaviour via interactions with CCK(1) receptors in the rat. Neuropharmacology 2001; 40: 818-825.
33. Barros HM, Tannhauser SL, Tannhauser MA, Tannhauser M. The effects of GABAergic drugs on grooming behaviour in the open field. Pharmacol Toxicol 1994; 74: 339-344.
34. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987; 92: 180-185.
35. Rogerio R, Takahashi RN. Anxiogenic action of acute but not repeated cocaine administration in handling-habituated mice in the plus-maze test. Braz J Med Biol Res 1992; 25: 713-716.
36. Collin M, Hakansson-Ovesjo ML, Misane I, Ogren SO, Meister B. Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Brain Res Mol Brain Res 2000; 81: 51-61.
37. Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmacher T. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 2001; 73: 243-247.
38. Hunter RG, Philpot K, Vicentic A, Dominguez G, Hubert GW, Kuhar MJ. CART in feeding and obesity. Trends Endocrinol Metab 2004; 15: 454-459.
39. McAlister ED, Van Vugt DA. Effect of leptin administration versus re-feeding on hypothalamic neuropeptide gone expression in fasted male rats. Can J Physiol Pharmacol 2004; 82: 1128-1134.
40. Kuhar MJ, Jaworski JN, Hubert GW, Philpot KB, Dominguez G. Cocaine- and amphetamine-regulated transcript peptides play a role in drug abuse and are potential therapeutic targets. AAPS J 2005; 7: E259-E265.